240 related articles for article (PubMed ID: 36596591)
1. Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation.
Zhang B; Li J; Hua Q; Wang H; Xu G; Chen J; Zhu Y; Li R; Liang Q; Wang L; Jin M; Tang J; Lin Z; Zhao L; Zhang D; Yu D; Ren J; Zhang T
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36596591
[TBL] [Abstract][Full Text] [Related]
2. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
[TBL] [Abstract][Full Text] [Related]
3. Selective autophagy of MHC-I promotes immune evasion of pancreatic cancer.
Yamamoto K; Venida A; Perera RM; Kimmelman AC
Autophagy; 2020 Aug; 16(8):1524-1525. PubMed ID: 32459143
[TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.
Kim Y; Konda P; Murphy JP; Paulo JA; Gygi SP; Gujar S
Mol Cell Proteomics; 2022 Feb; 21(2):100182. PubMed ID: 34922008
[TBL] [Abstract][Full Text] [Related]
5. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
7. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.
Bao Y; Qiao Y; Choi JE; Zhang Y; Mannan R; Cheng C; He T; Zheng Y; Yu J; Gondal M; Cruz G; Grove S; Cao X; Su F; Wang R; Chang Y; Kryczek I; Cieslik M; Green MD; Zou W; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2314416120. PubMed ID: 38011559
[TBL] [Abstract][Full Text] [Related]
8. CD4
Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
10. Targeting cathepsin B by cycloastragenol enhances antitumor immunity of CD8 T cells via inhibiting MHC-I degradation.
Deng G; Zhou L; Wang B; Sun X; Zhang Q; Chen H; Wan N; Ye H; Wu X; Sun D; Sun Y; Cheng H
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36307151
[TBL] [Abstract][Full Text] [Related]
11. Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.
Nguyen EM; Taniguchi H; Chan JM; Zhan YA; Chen X; Qiu J; de Stanchina E; Allaj V; Shah NS; Uddin F; Manoj P; Liu M; Cai SF; Levine R; Quintanal-Villalonga Á; Sen T; Chow A; Rudin CM
J Thorac Oncol; 2022 Aug; 17(8):1014-1031. PubMed ID: 35691495
[TBL] [Abstract][Full Text] [Related]
12. Mouse Norovirus Infection Reduces the Surface Expression of Major Histocompatibility Complex Class I Proteins and Inhibits CD8
Fritzlar S; Jegaskanda S; Aktepe TE; Prier JE; Holz LE; White PA; Mackenzie JM
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976673
[TBL] [Abstract][Full Text] [Related]
13. Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation.
Du W; Hua F; Li X; Zhang J; Li S; Wang W; Zhou J; Wang W; Liao P; Yan Y; Li G; Wei S; Grove S; Vatan L; Zgodziński W; Majewski M; Wallner G; Chen H; Kryczek I; Fang JY; Zou W
Cancer Discov; 2021 Jul; 11(7):1826-1843. PubMed ID: 33627378
[TBL] [Abstract][Full Text] [Related]
14. Diacylglycerol kinase α regulates tubular recycling endosome biogenesis and major histocompatibility complex class I recycling.
Xie S; Naslavsky N; Caplan S
J Biol Chem; 2014 Nov; 289(46):31914-31926. PubMed ID: 25248744
[TBL] [Abstract][Full Text] [Related]
15. MHC Class I Internalization via Autophagy Proteins.
Loi M; Ligeon LA; Münz C
Methods Mol Biol; 2019; 1880():455-477. PubMed ID: 30610715
[TBL] [Abstract][Full Text] [Related]
16. Tumor immune evasion through loss of MHC class-I antigen presentation.
Sari G; Rock KL
Curr Opin Immunol; 2023 Aug; 83():102329. PubMed ID: 37130455
[TBL] [Abstract][Full Text] [Related]
17. LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression.
Yang Q; Lv Z; Wang M; Kong M; Zhong C; Gao K; Wan X
J Exp Clin Cancer Res; 2024 Feb; 43(1):54. PubMed ID: 38383447
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.
Chen Y; Sun J; Liu J; Wei Y; Wang X; Fang H; Du H; Huang J; Li Q; Ren G; Wang X; Li H
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38088186
[TBL] [Abstract][Full Text] [Related]
19. miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8
Zheng J; Yang T; Gao S; Cheng M; Shao Y; Xi Y; Guo L; Zhang D; Gao W; Zhang G; Yang L; Yang T
FASEB J; 2021 Aug; 35(8):e21776. PubMed ID: 34324740
[TBL] [Abstract][Full Text] [Related]
20. Constitutive internalization of murine MHC class I molecules.
Mahmutefendić H; Blagojević G; Kucić N; Lucin P
J Cell Physiol; 2007 Feb; 210(2):445-55. PubMed ID: 17044074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
